Cosciens Biopharma Inc.TSX: CSCI

Aeterna Zentaris Announces Exercise of Last Series B Warrants Covered by November 1, 2015 Agreement

· Issued by Cosciens Biopharma Inc.

Philip Theodore, Senior Vice President, ptheodore@aezsinc.comCopyright CNW Group 2015